StockNews.com Begins Coverage on Cutera (NASDAQ:CUTR)

StockNews.com started coverage on shares of Cutera (NASDAQ:CUTR) in a research report issued on Saturday. The firm set a “sell” rating on the medical device company’s stock.

Cutera Price Performance

Cutera stock opened at $0.43 on Friday. The firm has a 50 day simple moving average of $0.42 and a 200-day simple moving average of $0.57. Cutera has a 1-year low of $0.28 and a 1-year high of $3.00. The stock has a market cap of $8.68 million, a price-to-earnings ratio of -0.07 and a beta of 1.32.

Hedge Funds Weigh In On Cutera

A hedge fund recently bought a new stake in Cutera stock. Sculptor Capital LP acquired a new position in shares of Cutera, Inc. (NASDAQ:CUTR) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 166,000 shares of the medical device company’s stock, valued at approximately $59,000. Sculptor Capital LP owned 0.82% of Cutera as of its most recent filing with the SEC. 90.70% of the stock is currently owned by hedge funds and other institutional investors.

About Cutera

Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform.